Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,663.60
(
-0.24%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
106.61
(
2.08%
)
Bitcoin
70,696.02
(
1.14%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rfj1862

Send PM Follow Ignore
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

rfj1862

Re: DewDiligence post# 43414

Thursday, 03/22/2007 3:52:06 PM

Thursday, March 22, 2007 3:52:06 PM

Post# of 257262
It's excellent news for Novartis because Exforge can launch early. Exforge is the combination of an ARB and amlodipine (Norvasc).

Like hydrochlorothiazide, every pharmaceutical company is going to come out with an amlodipine/product combination now. Norvasc is a great drug.

[Edit: oops, I see the answer has already been given. I didn't peek. Really]
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now